This Blood Thinner Is More Effective Than Aspirin at Preventing Heart Attacks

One of the aspirin Risky patients have been recommended for decades as a way to protect against heart attack and stroke among the most widely wide drugs in the world. However, a new study has shown that clopidogel, commonly used blood is thin or anticoulant, more effective in preventing severe heart attack and stroke and does not carry any additional risk.

This search is the result of research conducted by an international team of scientists in the United States, the United Kingdom, Switzerland, Australia and Japan. Their work is a meta-analysis-a study that collects and analyzes the results of multiple small studies, with more data to reach the more reliable conclusion. Total, this meta-analysis of about 29,000 patients diagnosed by coronary artery disease (CAD) saw clinical data, which is a condition where the fat is made of fat, which can have a secondary effect like heart attack and heart failure.

Experts conducted a systematic search of medical databases such as Pabmed, Scopus, Science Web and EMBS to find trials for CAD, published until April 12, 2025. The goal was to identify the papers comparing the effectiveness of aspirin clopidogel in preventing cardiovascular deaths, heart attacks and strokes.

The analysis was focused on seven investigations that include clinical information from people who have been treated for 2.5 years with aspirin or clopidogel with a confirmed case of CAD. After the 5.5 year follow -up, researchers observed that clopidogel receipts were 14 percent less risk of a larger cardiovascular event than people treated with aspirin.

In the end, the party has reached the conclusion that these searches add to the “proof that the clopidogel is higher than aspirin to prevent large adverse cardiac and cerebrovascular events.” In the view of the researchers, these quest supports the use of aspirin on established CAD infected patients so that they try to prevent major complications as a result of their condition like a heart attack. The search was published in the journal LanesetThe

In case of mortality and bleeding risk, meta-analysis has reached the conclusion that both groups were the same, confirming that clopidogel aspirin is as safe.

“All of our knowledge is the only antiplelet treatment that is the only antiplelet treatment that has demonstrated more effectiveness than aspirin without compromising with protection,” researchers wrote on paper.

The invention can convert to internationally treatment guidelines. Clopidogel is a widely available, affordable drug that makes reliable generic versions, features that make it easy to include in routine clinical practice. Nevertheless, experts emphasized that more extensive research is needed to assess the cost-effectiveness of clopidogel and its effectiveness in various populations to support its inclusion in the quality of treatment.

Cardiovascular diseases are the main cause of the world’s death. According to the World Health Organization, an approximate 17.9 million people Die every year from these conditions. More than four out of every five of these deaths are due to coronary heart disease or stroke. New research suggests that clopidographer can become the main alternative to dealing with this public health problem, whose incidents continue to grow worldwide.

This story was originally attended Wired In Spanish And have been translated from Spanish.